Vincenza Nigro
Corporate Officer/Principal chez HANSA BIOPHARMA AB
Profil
Vincenza Nigro is currently the Vice President-Global Medical Affairs at Hansa Biopharma AB since 2018.
Prior to this, she was the Head-Medical Affairs at Veloxis Pharmaceuticals A.
Nigro holds an MBA from the Massachusetts Institute of Technology and an undergraduate degree from Fairleigh Dickinson University.
Postes actifs de Vincenza Nigro
| Sociétés | Poste | Début |
|---|---|---|
| HANSA BIOPHARMA AB | Corporate Officer/Principal | 17/09/2018 |
Anciens postes connus de Vincenza Nigro
| Sociétés | Poste | Fin |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Chief Tech/Sci/R&D Officer | - |
Formation de Vincenza Nigro
| Massachusetts Institute of Technology | Masters Business Admin |
| Fairleigh Dickinson University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HANSA BIOPHARMA AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
